is now

Please update your bookmarks and favorites.
You will be taken to the new site in a few seconds.

Prevalence of Rectal Carcinoid Tumors among Outpatient Colonoscopy Patients and the Utility of Immunohistochemistry for Definitive Diagnosis

Rectal carcinoid tumors are rare (0.05% in the general population, SEER data) and are usually discovered incidentally in routine colonoscopy biopsies. Although immunohistochemistry with neuroendocrine markers synaptophysin and/or chromogranin is often used to confirm the diagnosis, its utility is not well established. The aims of this study were to (1) determine the prevalence of rectal carcinoid tumors in a large cohort of US outpatient colonoscopy patients and (2) evaluate whether the routine use of immunohistochemical stains is necessary for a definitive diagnosis.

To read the rest of this article, please contact Miraca Life Sciences

Choose Inform Diagnostics for Your Patients

Learn more about Inform Diagnostics' pathology services

Learn More »
TRADESHOWS >> FIND posters and presentations from past shows, and see where Miraca Life Sciences will be next.

And if you’re using EMA, you sure should be using Miraca. I can’t express enough how helpful Miraca has been to us.
— Rihanna Flanagan, PA-C,
Associates South Shore Dermatology, Quincy, Mass.

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.